- Home
- GPRO vs FENC Comparison
GPRO vs FENC Comparison
Compare GPRO & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- FENC
- Stock Information
- Founded
- GPRO 2004
- FENC 1996
- Country
- GPRO United States
- FENC United States
- Employees
- GPRO 696
- FENC N/A
- Industry
- GPRO Industrial Machinery/Components
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GPRO Consumer Discretionary
- FENC Health Care
- Exchange
- GPRO Nasdaq
- FENC Nasdaq
- Market Cap
- GPRO 118.4M
- FENC 222.9M
- IPO Year
- GPRO 2014
- FENC 2001
- Fundamental
- Price
- GPRO $0.74
- FENC $8.40
- Analyst Decision
- GPRO Hold
- FENC Strong Buy
- Analyst Count
- GPRO 1
- FENC 2
- Target Price
- GPRO $1.50
- FENC $13.00
- AVG Volume (30 Days)
- GPRO 5.2M
- FENC 80.0K
- Earning Date
- GPRO 08-05-2025
- FENC 08-12-2025
- Dividend Yield
- GPRO N/A
- FENC N/A
- EPS Growth
- GPRO N/A
- FENC N/A
- EPS
- GPRO N/A
- FENC N/A
- Revenue
- GPRO $780,312,000.00
- FENC $30,912,000.00
- Revenue This Year
- GPRO N/A
- FENC $0.85
- Revenue Next Year
- GPRO $6.79
- FENC $55.16
- P/E Ratio
- GPRO N/A
- FENC N/A
- Revenue Growth
- GPRO N/A
- FENC N/A
- 52 Week Low
- GPRO $0.40
- FENC $3.96
- 52 Week High
- GPRO $1.76
- FENC $8.88
- Technical
- Relative Strength Index (RSI)
- GPRO 47.74
- FENC 63.33
- Support Level
- GPRO $0.67
- FENC $7.94
- Resistance Level
- GPRO $0.95
- FENC $8.51
- Average True Range (ATR)
- GPRO 0.06
- FENC 0.41
- MACD
- GPRO -0.02
- FENC -0.01
- Stochastic Oscillator
- GPRO 26.26
- FENC 89.80
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.